The Clinical Significance of Serum Interleukin-36α Levels in Patients with Gout

References

• Bardin, T., & Richette, P. (2019). Defining remission in patients with gout. Nature Reviews Rheumatology, 15(9), 516–517. https://doi.org/10.1038/s41584-019-0280-0
   PubMed Web of Science ®Google Scholar
• Boutet, M. A., Bart, G., Penhoat, M., Amiaud, J., Brulin, B., Charrier, C., Morel, F., Lecron, J. C., Rolli-Derkinderen, M., Bourreille, A., Vigne, S., Gabay, C., Palmer, G., Le Goff, B., & Blanchard, F. (2016). Distinct expression of interleukin (IL)-36 α, β and γ their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn’s disease. Clinical and Experimental Immunology, 184(2), 159–173. https://doi.org/10.1111/cei.12761
   PubMed Web of Science ®Google Scholar
• Chen-Xu, M., Yokose, C., Rai, S. K., Pillinger, M. H., & Choi, H. K. (2019). Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: The national health and nutrition examination survey, 2007–2016. Arthritis and Rheumatology, 71(6), 991–999. https://doi.org/10.1002/art.40807
   PubMed Web of Science ®Google Scholar
• Chi, H. H., Hua, K. F., Lin, Y. C., Chu, C. L., Hsieh, C. Y., Hsu, Y. J., Ka, S. M., Tsai, Y. L., Liu, F. C., & Chen, A. (2017). IL-36 signaling facilitates activation of the NLRP3 inflammasome and IL-23/IL-17 axis in renal inflammation and fibrosis. Journal of the American Society of Nephrology, 28(7), 2022–2037. https://doi.org/10.1681/ASN.2016080840
   PubMed Web of Science ®Google Scholar
• Dalbeth, N., Gosling, A. L., Gaffo, A., & Abhishek, A. (2021). Gout. Lancet, 397(10287), 1843–1855. https://doi.org/10.1016/S0140-6736(21)00569-9
   PubMed Web of Science ®Google Scholar
• Guagnano, M. T., D’Ardes, D., Ilaria, R., Santilli, F., Schiavone, C., Bucci, M., & Cipollone, F. (2022). Non- alcoholic fatty liver disease and metabolic syndrome in women: Effects of lifestyle modifications. Journal of Clinical Medicine, 11(10), 2759. https://doi.org/10.3390/jcm11102759
   PubMed Web of Science ®Google Scholar
• Hainer, B. L., Matheson, E., & Wilkes, R. T. (2014). Diagnosis, treatment, and prevention of gout. American Family Physician, 90(12), 831–836.
   PubMed Web of Science ®Google Scholar
• Hao, Z., & Liu, Y. (2021). IL-38 and IL-36 target autophagy for regulating synoviocyte proliferation, migration, and invasion in rheumatoid arthritis. Disease Markers, 2021, 1–11. https://doi.org/10.1155/2021/7933453
   Web of Science ®Google Scholar
• Hessam, S., Sand, M., Gambichler, T., Skrygan, M., Rüddel, I., & Bechara, F. G. (2018). Interleukin‐36 in hidradenitis suppurativa: Evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop. British Journal of Dermatology, 178(3), 761–767. https://doi.org/10.1111/bjd.16019
   PubMed Web of Science ®Google Scholar
• Hojen, J. F., Kristensen, M. L. V., McKee, A. S., Wade, M. T., Azam, T., Lunding, L. P., de Graaf, D. M., Swartzwelter, B. J., Wegmann, M., Tolstrup, M., Beckman, K., Fujita, M., Fischer, S., & Dinarello, C. A. (2019). IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease. Nature Immunology, 20(9), 1138–1149. https://doi.org/10.1038/s41590-019-0467-1
   PubMed Web of Science ®Google Scholar
• Keller, S. F., & Mandell, B. F. (2021). Management and cure of gouty arthritis. The Medical Clinics of North America, 105(2), 297–310. https://doi.org/10.1016/j.mcna.2020.09.013
   PubMed Web of Science ®Google Scholar
• Kluck, V., van Deuren, R. C., Cavalli, G., Shaukat, A., Arts, P., Cleophas, M. C., Crisan, T. O., Tausche, A. K., Riches, P., Dalbeth, N., Stamp, L. K., Hindmarsh, J. H., Jansen, T., Janssen, M., Steehouwer, M., Lelieveld, S., van de Vorst, M., Gilissen, C., … Joosten, L. A. (2020). Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout. Annals of the Rheumatic Diseases, 79(4), 536–544. https://doi.org/10.1136/annrheumdis-2019-216233
   PubMed Web of Science ®Google Scholar
• Kumar, S., McDonnell, P. C., Lehr, R., Tierney, L., Tzimas, M. N., Griswold, D. E., Capper, E. A., Tal-Singer, R., Wells, G. I., Doyle, M. L., & Young, P. R. (2000). Identification and initial characterization of four novel members of the interleukin-1 family. Journal of Biological Chemistry, 275(14), 10308–10314. https://doi.org/10.1074/jbc.275.14.10308
   PubMed Web of Science ®Google Scholar
• Kuo, C. F., Grainge, M. J., Mallen, C., Zhang, W., & Doherty, M. (2016). Comorbidities in patients with gout prior to and following diagnosis: Case-control study. Annals of the Rheumatic Diseases, 75(1), 210–217. https://doi.org/10.1136/annrheumdis-2014-206410
   PubMed Web of Science ®Google Scholar
• Kuo, C. F., Grainge, M. J., Zhang, W., & Doherty, M. (2015). Global epidemiology of gout: Prevalence, incidence and risk factors. Nature Reviews Rheumatology, 11, 649–662. https://doi.org/10.1038/nrrheum.2015.91
   PubMed Web of Science ®Google Scholar
• Li, L., Shan, S., Kang, K., Zhang, C., Kou, R., & Song, F. (2021). The cross-talk of NLRP3 inflammasome activation and necroptotic hepatocyte death in acetaminophen-induced mice acute liver injury. Human & Experimental Toxicology, 40(4), 673–684. https://doi.org/10.1177/0960327120961158
   PubMed Web of Science ®Google Scholar
• Liu, W., Song, H., Man, S., Li, H., & Gao, S. (2021). Simple metabolic markers associated with tophaceous gout. Clinical Rheumatology, 40(12), 5047–5053. https://doi.org/10.1007/s10067-021-05861-x
   PubMed Web of Science ®Google Scholar
• Martinon, F., Burns, K., & Tschopp, J. (2002). The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Molecular Cell, 10(2), 417–426. https://doi.org/10.1016/S1097-2765(02)00599-3
   PubMed Web of Science ®Google Scholar
• Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006). Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature, 440(7081), 237–241. https://doi.org/10.1038/nature04516
   PubMed Web of Science ®Google Scholar
• McGrowder, D. A., Miller, F., Anderson Cross, M., Anderson-Jackson, L., Bryan, S., & Dilworth, L. (2021). Abnormal liver biochemistry tests and acute liver injury in COVID-19 patients: Current evidence and potential pathogenesis. Diseases, 9(3), 50. https://doi.org/10.3390/diseases9030050
   PubMedGoogle Scholar
• Nuki, G. (2014). An appraisal of the 2012 American college of rheumatology guidelines for the management of gout. Current Opinion in Rheumatology, 26(2), 152–161. https://doi.org/10.1097/BOR.0000000000000034
   PubMed Web of Science ®Google Scholar
• Scuiller, A., Pascart, T., Bernard, A., & Oehler, E. (2020). [ Gout]. La maladie goutteuse. La Revue de Médecine Interne, 41(6), 396–403. https://doi.org/10.1016/j.revmed.2020.02.014
   PubMedGoogle Scholar
• Singh, J. A., Herbey, I., Bharat, A., Dinnella, J. E., Pullman-Mooar, S., Eisen, S., & Ivankova, N. (2017). Gout self-management in African American veterans: A qualitative exploration of challenges and solutions from patients’ perspectives. Arthritis Care & Research, 69(11), 1724–1732. https://doi.org/10.1002/acr.23202
   Web of Science ®Google Scholar
• Slobodnick, A., Shah, B., Krasnokutsky, S., & Pillinger, M. H. (2018). Update on colchicine, 2017. Rheumatology (Oxford), 57(suppl_1), i4–i11. https://doi.org/10.1093/rheumatology/kex453
   PubMedGoogle Scholar
• So, A., Dumusc, A., & Nasi, S. (2018). The role of IL-1 in gout: From bench to bedside. Rheumatology (Oxford), 57(suppl_1), i12–i19. https://doi.org/10.1093/rheumatology/kex449
   PubMedGoogle Scholar
• Sookoian, S., & Pirola, C. J. (2015). Liver enzymes, metabolomics and genome-wide association studies: From systems biology to the personalized medicine. World Journal of Gastroenterology, 21(3), 711–725. https://doi.org/10.3748/wjg.v21.i3.711
   PubMed Web of Science ®Google Scholar
• Stamp, L. K., & Dalbeth, N. (2019). Prevention and treatment of gout. Nature Reviews Rheumatology, 15, 68–70. https://doi.org/10.1038/s41584-018-0149-7
   PubMed Web of Science ®Google Scholar
• Taylor, W. J., Fransen, J., Jansen, T. L., Dalbeth, N., Schumacher, H. R., Brown, M., Louthrenoo, W., Vazquez-Mellado, J., Eliseev, M., McCarthy, G., Stamp, L. K., Perez-Ruiz, F., Sivera, F., Ea, H. K., Gerritsen, M., Scire, C., Cavagna, L., Lin, C., … Neogi, T. (2015). Study for updated gout classification criteria: Identification of features to classify gout. Arthritis Care & Research, 67(9), 1304–1315. https://doi.org/10.1002/acr.22585
   Web of Science ®Google Scholar
• Toprover, M., Krasnokutsky, S., & Pillinger, M. H. (2015). Gout in the spine: Imaging, diagnosis, and outcomes. Current Rheumatology Reports, 17(12), 70. https://doi.org/10.1007/s11926-015-0547-7
   PubMed Web of Science ®Google Scholar
• Towne, J. E., Renshaw, B. R., Douangpanya, J., Lipsky, B. P., Shen, M., Gabel, C. A., & Sims, J. E. (2011). Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity. Journal of Biological Chemistry, 286(49), 42594–42602. https://doi.org/10.1074/jbc.M111.267922
   PubMed Web of Science ®Google Scholar
• Troseid, M., Seljeflot, I., Hjerkinn, E. M., & Arnesen, H. (2009). Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: Synergistic effect of inflammation and hyperglycemia. Diabetes Care, 32(3), 486–492. https://doi.org/10.2337/dc08-1710
   PubMed Web of Science ®Google Scholar
• Wang, W., Yu, X., Wu, C., & Jin, H. (2017). IL-36γ inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis. International Journal of Medical Sciences, 14(10), 1002–1007. https://doi.org/10.7150/ijms.20809
   PubMed Web of Science ®Google Scholar
• Xue, Y., Li, R., Fang, P., Ye, Z. Q., Zhao, Y., Zhou, Y., Zhang, K. Q., & Li, L. (2021). NLRP3 inflammasome inhibitor cucurbitacin B suppresses gout arthritis in mice. Journal of Molecular Endocrinology, 67(2), 27–40. https://doi.org/10.1530/JME-20-0305
   PubMed Web of Science ®Google Scholar
• Yin, C., Liu, B., Li, Y., Li, X., Wang, J., Chen, R., Tai, Y., Shou, Q., Wang, P., Shao, X., Liang, Y., Zhou, H., Mi, W., Fang, J., & Liu, B. (2020). IL-33/ST2 induces neutrophil-dependent reactive oxygen species production and mediates gout pain. Theranostics, 10(26), 12189–12203. https://doi.org/10.7150/thno.48028
   PubMed Web of Science ®Google Scholar
• Yu, W., & Cheng, J. D. (2020). Uric Acid and cardiovascular disease: An update from molecular mechanism to clinical perspective. Frontiers in Pharmacology, 11, 582680. https://doi.org/10.3389/fphar.2020.582680
   PubMed Web of Science ®Google Scholar
• Zhou, J., Dai, Y., Lin, Y., & Chen, K. (2022). Association between serum amyloid a and rheumatoid arthritis: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 52, 151943. https://doi.org/10.1016/j.semarthrit.2021.12.011
   PubMed Web of Science ®Google Scholar